A promising future blood biomarker is neurofilament light protein (NfL), an axonal neuron-specific protein increased in AD and Mild cognitive impairment (MCI) patients, but also in other neurodegenerative disorders such as frontotemporal dementia (FTD) [[45], [46], [47]]. This evidence concerns the gene NEFL and Alzheimer disease.